NCT03199885 2025-12-30Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerNational Cancer Institute (NCI)Phase 3 Completed190 enrolled 12 charts
NCT00551421 2015-03-31Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerNational Cancer Institute (NCI)Phase 1/2 Completed17 enrolled 7 charts